Your browser version may not work well with NCBI's Web applications. More information here...
1: J Neurosci Res. 2005 Apr 15;80(2):151-9.Click here to read Links

Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.

Kerr ML, Small DH.

Laboratory of Molecular Neurobiology, Department of Biochemistry and Molecular Biology, and Monash University Centre for Brain and Behaviour, Monash University, Victoria, Australia.

The beta-amyloid protein precursor (APP) has been extensively studied for its role in amyloid production and the pathogenesis of Alzheimer's disease (AD). However, little is known about the normal function of APP and its biological interactions. In this Mini-Review, the role of the cytoplasmic domain of APP in APP trafficking and proteolysis is described. These studies suggest that proteins that bind to the cytoplasmic domain may be important targets for drug development in AD. 2005 Wiley-Liss, Inc.

PMID: 15672415 [PubMed - indexed for MEDLINE]